NRC Financials Nrc Health

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Aug 9, 2026, 10:18 UTC Overview →

Growth & profitability

Revenue has grown 0.6% per year over the past 5 years.
Net income has grown slower than revenue (-25.4% vs 0.6% per year).
Operating margin has contracted, at 16.4% in the latest year.
Free cash flow has declined 15.5% per year over the past 5 years.

Financial health

Total debt ($79M) exceeds cash ($4M); net debt is $75M.
Total debt has grown faster than revenue (20.8% vs 0.6% per year).
Operating income covered interest expense 4.7× in the latest year.
Total debt is 2.6× EBITDA.

Shareholder returns

Dividends have been paid for 11 consecutive years, consuming 94.6% of earnings and 69.7% of free cash flow.
The dividend has grown 0.9% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$137M	$12M	0.0%	16.4%	82.9%	8.6%	$16M	$79M	$4M
2024	$143M	$25M	0.0%	24.6%	79.2%	18.7%	$19M	$58M	$4M
2023	$149M	$31M	0.0%	27.0%	63.3%	25.3%	$22M	$37M	$7M
2022	$152M	$32M	0.0%	30.7%	44.1%	24.4%	$26M	$22M	$25M
2021	$148M	$37M	0.0%	34.0%	43.9%	23.8%	$41M	$27M	$54M
2020	$133M	—	0.0%	32.0%	0.0%	0.0%	$37M	$31M	$35M
2019	$128M	—	0.0%	33.6%	0.0%	0.0%	$36M	$34M	$14M
2018	$120M	$30M	0.0%	29.5%	157.5%	27.8%	$34M	$38M	$13M
2017	$118M	$23M	0.0%	29.1%	25.5%	18.0%	$24M	$1M	$35M
2016	—	$21M	—	—	24.8%	17.0%	$23M	$4M	$33M
2015	—	$18M	—	—	23.7%	13.8%	$19M	$6M	$42M
2014	—	$18M	—	—	20.7%	14.0%	$24M	$8M	$40M
2013	—	$15M	—	—	21.6%	13.9%	$17M	$10M	$22M
2012	—	$15M	—	—	26.6%	15.1%	$17M	$12M	$8M
2011	—	$12M	—	—	20.8%	11.5%	$16M	$14M	$8M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Jun '26	$35M	-$3M	0.0%	-9.1%	-50.1%	-2.4%	$62000	$90M	$3M
Mar '26	$35M	$3M	0.0%	16.0%	23.9%	2.4%	$5M	$74M	$3M
Dec '25	$35M	—	0.0%	13.3%	0.0%	0.0%	$6M	$79M	$4M
Sep '25	$35M	—	0.0%	22.4%	0.0%	0.0%	$10M	$76M	$2M
Jun '25	$34M	-$106000	0.0%	4.7%	-0.5%	-0.1%	-$4M	$77M	$5M
Mar '25	$34M	$6M	0.0%	25.6%	19.5%	4.3%	$4M	$59M	$3M
Dec '24	$37M	—	0.0%	26.0%	0.0%	0.0%	$2M	$58M	$4M
Sep '24	$36M	—	0.0%	22.3%	0.0%	0.0%	$8M	$49M	$3M
Jun '24	$35M	—	0.0%	25.3%	0.0%	0.0%	$2M	$33M	$485000
Mar '24	$35M	—	0.0%	24.8%	0.0%	0.0%	$8M	$35M	$2M
Dec '23	$38M	—	0.0%	30.8%	0.0%	0.0%	$8M	$37M	$7M
Sep '23	$38M	—	0.0%	26.2%	0.0%	0.0%	$5M	$19M	$4M
Jun '23	$36M	—	0.0%	25.9%	0.0%	0.0%	$4M	$20M	$22M
Mar '23	$36M	—	0.0%	24.7%	0.0%	0.0%	$5M	$21M	$24M
Dec '22	$38M	—	0.0%	32.1%	0.0%	0.0%	$6M	$22M	$25M
Sep '22	$38M	—	0.0%	29.5%	0.0%	0.0%	$6M	$23M	$28M
Jun '22	$37M	—	0.0%	30.8%	0.0%	0.0%	$8M	$24M	$33M
Mar '22	$38M	—	0.0%	30.4%	0.0%	0.0%	$6M	$26M	$47M
Dec '21	$38M	—	0.0%	33.6%	0.0%	0.0%	$10M	$27M	$54M
Sep '21	$38M	—	0.0%	34.8%	0.0%	0.0%	$8M	$28M	$52M

Valuation over time

How the market has priced NRC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 30.3× (Mar '23) to 46.2× (Nov '26).
The price-to-sales ratio has fallen from 6.3× (Mar '23) to 3.9× (Nov '26).
The dividend yield has fallen from 2.2% (Mar '23) to 2.0% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is NRC growing its revenue and profit?

Over the past 5 years, Nrc Health's revenue has grown 0.6% per year, and net income declined 25.4% per year. These are computed facts, not advice.

How much debt does NRC have?

As of FY2025, Nrc Health reported $79M of total debt against $4M of cash; operating income covered interest expense 4.7×.

What is NRC's profit margin?

In FY2025, gross margin was —, operating margin 16.4%, and net margin 8.4%.

What is NRC's P/E ratio?

Nrc Health's P/E (TTM) is 46.18 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the NRC stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 46.2× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.